The interest in Platelet Rich Plasma (PRP) rose dramatically last week according to Google Trends. This autologous biologic product and treatment continues to gain traction as a simple way to address challenging problems such as chronic tennis elbow. As more clinicians, researchers and patients gain experience with it, better formulations and protocols will be developed to treat injuries and disorders safely and effectively.
We are now in the second decade of using PRP therapeutically and this trend is a signpost of worldwide interest. This interest will also spark new innovations surrounding the use of blood therapeutically.
Patients and even payers will benefit from blood based breakthroughs because many newer biologic procedures will be as or more effective than surgery and less costly.
Sign up for a free PRP and Biologic Orthopedic Newsletter.